Midazolam as Adjunct Therapy to Morphine in the Alleviation of Severe Dyspnea Perception in Patients with Advanced Cancer
- 1 January 2006
- journal article
- research article
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 31 (1) , 38-47
- https://doi.org/10.1016/j.jpainsymman.2005.06.009
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Absolute bioavailability of midazolam after subcutaneous administration to healthy volunteersBritish Journal of Clinical Pharmacology, 2002
- Factors Correlated with Dyspnea in Advanced Lung Cancer PatientsJournal of Pain and Symptom Management, 2002
- An investigation of the potential morphine sparing effect of midazolamAnaesthesia, 1996
- Prevalence of symptoms among patients with advanced cancer: An international collaborative studyJournal of Pain and Symptom Management, 1996
- National survey of drug use in palliative carePalliative Medicine, 1996
- Midazolam reduces vomiting after tonsillectomy in childrenCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1995
- Plasma concentrations of midazolam during continuous subcutaneous administration in palliative ca rePalliative Medicine, 1994
- Midazolam in terminal careAmerican Journal of Hospice and Palliative Medicine®, 1993
- Sedation for upper gastrointestinal endoscopy: results of a nationwide survey.Gut, 1991
- Review article: premedication and intravenous sedation for upper gastrointestinal endoscopyAlimentary Pharmacology & Therapeutics, 1990